April 30 (SeeNews) - Bulgarian pharmaceuticals maker Sopharma [BUL:SFA] said on Wednesday that its standalone net profit declined to 12.4 million levs ($7.2 million/6.3 million euro) in January-March from some 15.2 million levs in the prior-year period.